Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Friends | 1 | 2019 | 25 | 0.660 |
Why?
|
Shock, Septic | 5 | 2017 | 186 | 0.660 |
Why?
|
Attitude to Death | 1 | 2019 | 102 | 0.630 |
Why?
|
Frail Elderly | 1 | 2019 | 123 | 0.620 |
Why?
|
Interpersonal Relations | 1 | 2019 | 280 | 0.570 |
Why?
|
Family | 1 | 2019 | 762 | 0.490 |
Why?
|
Advanced Practice Nursing | 1 | 2010 | 14 | 0.360 |
Why?
|
Nurse's Role | 1 | 2010 | 45 | 0.350 |
Why?
|
Pediatric Nursing | 1 | 2010 | 38 | 0.350 |
Why?
|
Critical Care | 3 | 2017 | 808 | 0.350 |
Why?
|
Palliative Care | 3 | 2013 | 2154 | 0.330 |
Why?
|
Continuity of Patient Care | 1 | 2010 | 223 | 0.300 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2017 | 637 | 0.300 |
Why?
|
Compartment Syndromes | 1 | 2007 | 33 | 0.280 |
Why?
|
Organizational Policy | 1 | 2007 | 79 | 0.280 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 101 | 0.280 |
Why?
|
Terminally Ill | 1 | 2007 | 96 | 0.270 |
Why?
|
Withholding Treatment | 1 | 2007 | 155 | 0.270 |
Why?
|
Abdomen | 1 | 2007 | 348 | 0.250 |
Why?
|
Catheterization | 1 | 2007 | 423 | 0.240 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 2 | 2015 | 181 | 0.220 |
Why?
|
Critical Illness | 1 | 2005 | 742 | 0.170 |
Why?
|
Hyperthermia, Induced | 2 | 2015 | 510 | 0.170 |
Why?
|
Mexico | 1 | 2019 | 274 | 0.160 |
Why?
|
Resuscitation | 2 | 2017 | 265 | 0.150 |
Why?
|
Patient Care Bundles | 1 | 2017 | 30 | 0.140 |
Why?
|
Hospitals, Pediatric | 2 | 2010 | 789 | 0.110 |
Why?
|
Hemodynamics | 3 | 2017 | 971 | 0.110 |
Why?
|
Cordotomy | 1 | 2013 | 47 | 0.100 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2013 | 88 | 0.100 |
Why?
|
Child | 11 | 2017 | 30418 | 0.100 |
Why?
|
Pain, Intractable | 1 | 2013 | 179 | 0.100 |
Why?
|
Models, Nursing | 1 | 2010 | 10 | 0.090 |
Why?
|
Cytoreduction Surgical Procedures | 1 | 2015 | 508 | 0.090 |
Why?
|
Empathy | 1 | 2010 | 103 | 0.080 |
Why?
|
Program Development | 1 | 2010 | 264 | 0.080 |
Why?
|
Patient Care Planning | 1 | 2010 | 307 | 0.080 |
Why?
|
Texas | 2 | 2010 | 6415 | 0.070 |
Why?
|
Child, Preschool | 6 | 2015 | 16978 | 0.070 |
Why?
|
Medulloblastoma | 1 | 2013 | 587 | 0.070 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2007 | 20 | 0.070 |
Why?
|
Forecasting | 1 | 2010 | 707 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 2426 | 0.070 |
Why?
|
United States | 3 | 2019 | 15982 | 0.070 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2010 | 476 | 0.070 |
Why?
|
Cisplatin | 1 | 2013 | 2493 | 0.070 |
Why?
|
Arkansas | 1 | 2005 | 60 | 0.060 |
Why?
|
Cancer Care Facilities | 1 | 2010 | 908 | 0.060 |
Why?
|
Peritoneal Dialysis | 1 | 2007 | 125 | 0.060 |
Why?
|
Patient Care Team | 1 | 2010 | 826 | 0.060 |
Why?
|
Protein C | 1 | 2004 | 31 | 0.060 |
Why?
|
Communication | 1 | 2010 | 859 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2007 | 348 | 0.060 |
Why?
|
Humans | 14 | 2019 | 270946 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2004 | 302 | 0.050 |
Why?
|
Male | 8 | 2019 | 128453 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 547 | 0.040 |
Why?
|
Pediatrics | 1 | 2009 | 1179 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2019 | 30940 | 0.040 |
Why?
|
Algorithms | 1 | 2010 | 3910 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2004 | 3075 | 0.040 |
Why?
|
Sepsis | 1 | 2004 | 689 | 0.040 |
Why?
|
Female | 6 | 2019 | 148508 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 7783 | 0.040 |
Why?
|
Infant | 3 | 2009 | 13913 | 0.040 |
Why?
|
Adult | 3 | 2019 | 81555 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4788 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 117 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2015 | 3972 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2017 | 188 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 10349 | 0.030 |
Why?
|
Middle Aged | 2 | 2019 | 90020 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 536 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2017 | 8591 | 0.030 |
Why?
|
Anesthesia | 1 | 2017 | 305 | 0.030 |
Why?
|
Aged | 1 | 2019 | 73160 | 0.030 |
Why?
|
Groin | 1 | 2013 | 78 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2015 | 39694 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 9043 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 16593 | 0.030 |
Why?
|
Hospice Care | 1 | 2013 | 160 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2017 | 1314 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 14679 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12516 | 0.020 |
Why?
|
Lower Extremity | 1 | 2013 | 284 | 0.020 |
Why?
|
Adolescent | 4 | 2015 | 32577 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2015 | 15253 | 0.020 |
Why?
|
Extracorporeal Circulation | 1 | 2009 | 55 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2015 | 13976 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 15849 | 0.020 |
Why?
|
Prognosis | 2 | 2015 | 22458 | 0.020 |
Why?
|
Biomarkers | 1 | 2017 | 5106 | 0.020 |
Why?
|
Necrosis | 1 | 2007 | 603 | 0.020 |
Why?
|
Young Adult | 2 | 2015 | 22059 | 0.020 |
Why?
|
Protein C Deficiency | 1 | 2004 | 12 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 4968 | 0.010 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2004 | 66 | 0.010 |
Why?
|
Antithrombins | 1 | 2004 | 62 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 13112 | 0.010 |
Why?
|
Hemorrhage | 1 | 2004 | 742 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2004 | 4399 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 33827 | 0.010 |
Why?
|
OKHUYSEN-CAWLEY's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_